Abstract
P068 <break /> Design of a randomized, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have